Clinical Scorecard: Are Women at Risk of Overexposure? A Review of Standardized Contrast Administration in Thoracoabdominal CT Imaging

At a Glance

Key Highlights

• Standardized contrast media volumes (100-120 mL) are commonly used but may not account for individual patient characteristics such as sex, body composition, or blood volume.
• Women may experience higher risk of adverse effects from iodinated contrast media, potentially due to higher relative exposure when using fixed contrast doses.
• Photon-counting detector CT (PCD-CT) enables spectral imaging allowing quantification of iodine contrast and identification of sex differences in contrast enhancement.

Guideline-Based Recommendations

Diagnosis

• Use portal-venous phase thoracoabdominal CT with standardized contrast injection protocols for malignancy evaluation.
• Employ PCD-CT spectral imaging to obtain virtual non-contrast images and iodine maps for accurate contrast quantification.

Management

• Administer iodinated contrast media volumes standardized at 100-120 mL for adult patients without renal impairment or low BMI.
• Consider individualized contrast dosing strategies based on patient sex, lean body weight, body surface area, or blood volume to optimize iodine contrast and minimize risks.

Monitoring & Follow-up

• Review contrast-enhanced images for sufficient attenuation by experienced radiologists to ensure diagnostic quality.
• Monitor patients for adverse reactions, especially women who may have increased susceptibility to contrast-induced complications.

Risks

• Be aware of risks including allergic reactions, contrast-induced nephropathy, and thyroid dysfunction associated with iodinated contrast media.
• Recognize that women may have a higher likelihood of adverse effects potentially related to fixed contrast dosing protocols.

Patient & Prescribing Data

Adults undergoing thoracoabdominal CT with suspected or known malignancy, excluding those with impaired renal function or very low BMI.

Fixed contrast media volumes of 100-120 mL are practical but may lead to sex-specific differences in iodine contrast enhancement; individualized dosing may reduce overexposure risks in women.

Clinical Best Practices

• Obtain complete patient characteristics (age, sex, height, weight) prior to contrast administration to inform dosing decisions.
• Exclude patients with impaired renal function or very low BMI from fixed-dose protocols to prevent inappropriate contrast exposure.
• Use biphasic contrast injection protocols with saline flush to optimize contrast distribution.
• Leverage spectral imaging capabilities of PCD-CT for precise iodine quantification and assessment of contrast enhancement.
• Ensure radiologists with adequate experience review scans to confirm diagnostic image quality and appropriate contrast attenuation.

References

• Contrast media use and optimization in CT imaging
• Sex differences in adverse reactions to iodinated contrast media
• Photon-counting detector CT technology and iodine quantification
• Individualized contrast dosing based on body composition